METTL3 and cancer: Functioning as an oncogene, Mettl3 facilitates the initiation and development of hematopoietic and solid malignancies by depositing m6A modifications on key transcriptional processes.[16,18] Cancer cells exploit Mettl3 to drive drug resistance (Fig. 2).